欧洲疾控中心：传染病威胁报告（2025年3月8-14日，第11周）（英文版）

There is currently significant respiratory virus activity in the EU/EEA. Intense seasonal influenza activity is being reported, together with a respiratory syncytial virus (RSV) epidemic, while SARS-CoV-2 activity is at a very low level. The biggest impact in secondary care has been in adults aged 65 years and above for influenza and in children under five years for RSV. Excess mortality has been observed since week 51, 2024, affecting adults aged 45 years and above. SARS-CoV-2 activity has b